Berberine mediates root remodeling in an immature tooth with apical periodontitis by regulating stem cells from apical papilla differentiation

Abstract

Once pulp necrosis or apical periodontitis occurs on immature teeth, the weak root and open root apex are challenging to clinicians. Berberine (BBR) is a potential medicine for bone disorders, therefore, we proposed to apply BBR in root canals to enhance root repair in immature teeth. An in vivo model of immature teeth with apical periodontitis was established in rats, and root canals were filled with BBR, calcium hydroxide or sterilized saline for 3 weeks. The shape of the roots was analyzed by micro-computed tomography and histological staining. In vitro, BBR was introduced into stem cells from apical papilla (SCAPs). Osteogenic differentiation of stem cells from apical papilla was investigated by alkaline phosphatase activity, mineralization ability, and gene expression of osteogenic makers. The signaling pathway, which regulated the osteogenesis of SCAPs was evaluated by quantitative real time PCR, Western blot analysis, and immunofluorescence. In rats treated with BBR, more tissue was formed, with longer roots, thicker root walls, and smaller apex diameters. In addition, we found that BBR promoted SCAPs osteogenesis in a time-dependent and concentration-dependent manner. BBR induced the expression of β-catenin and enhanced β-catenin entering into the nucleus, to up-regulate more runt-related nuclear factor 2 downstream. BBR enhanced root repair in immature teeth with apical periodontitis by activating the canonical Wnt/β-catenin pathway in SCAPs.

References

[1] Clark D, Levin L. Prognosis and complications of immature teeth following lateral luxation: a systematic review. Dent. Traumatol., 2018, 34: 215-220.

[2] Torabinejad M, Faras H. A clinical and histological report of a tooth with an open apex treated with regenerative endodontics using platelet-rich plasma. J. Endod., 2012, 38: 864-868.

[3] Wigler R, . Revascularization: a treatment for permanent teeth with necrotic pulp and incomplete root development. J. Endod., 2013, 39: 319-326.

[4] Moreno-Hidalgo MC, Caleza-Jimenez C, Mendoza-Mendoza A, Iglesias-Linares A. Revascularization of immature permanent teeth with apical periodontitis. Int. Endod. J., 2014, 47: 321-331.

[5] Silujjai J, Linsuwanont P. Treatment outcomes of apexification or revascularization in nonvital immature permanent teeth: a retrospective study. J. Endod., 2017, 43: 238-245.

[6] Harlamb SC. Management of incompletely developed teeth requiring root canal treatment. Aust. Dent. J., 2016, 61: 95-106.

[7] Kahler B, Rossi-Fedele G, Chugal N, Lin LM. An evidence-based review of the efficacy of treatment approaches for immature permanent teeth with pulp necrosis. J. Endod., 2017, 43: 1052-1057.

[8] Jung C, Kim S, Sun T, Cho YB, Song M. Pulp-dentin regeneration: current approaches and challenges. J. Tissue Eng., 2019, 10: 204173141881926.

[9] Kumar A, . Current knowledge and pharmacological profile of berberine: an update. Eur. J. Pharmacol., 2015, 761: 288-297.

[10] Wang H, Zhu C, Ying Y, Luo L, Huang D. Metformin and berberine, two versatile drugs in treatment of common metabolic diseases. Oncotarget, 2018, 9: 10135-10146.

[11] Imenshahidi M, Hosseinzadeh H. Berberine and barberry (Berberis vulgaris): a clinical review. Phytother. Res., 2019, 2016: 1-20.

[12] Wong, S. K., Chin, K.-Y. & Ima-Nirwana, S. Berberine and musculoskeletal disorders: the therapeutic potential and underlying molecular mechanisms. Phytomedicine https://doi.org/10.1016/j.phymed.2019.152892 (2019).

[13] Adil M, Nizam M, Singh D, Dattatraya A. ScienceDirect pioglitazone-induced bone loss in diabetic rats and its amelioration by berberine: a portrait of molecular crosstalk. Biomed. Pharmacother., 2017, 94: 1010-1019.

[14] Xie H, . Possible therapeutic potential of berberine in the treatment of STZ plus HFD-induced diabetic osteoporosis. Biomed. Pharmacother., 2018, 108: 280-287.

[15] Jia X, . Berberine ameliorates periodontal bone loss by regulating gut microbiota. J. Dent. Res., 2019, 98: 107-116.

[16] Xu D, Yang W, Zhou C, Liu Y, Xu B. Preventive effects of berberine on glucocorticoid-induced osteoporosis in rats. Planta Med., 2010, 76: 1809-1813.

[17] Hyun WL, . Berberine promotes osteoblast differentiation by Runx2 activation with p38 MAPK. J. Bone Miner. Res., 2008, 23: 1227-1237.

[18] Tao K, . Berberine promotes bone marrow-derived mesenchymal stem cells osteogenic differentiation via canonical Wnt/β-catenin signaling pathway. Toxicol. Lett., 2016, 240: 68-80.

[19] Tu HP, . Berberine’s effect on periodontal tissue degradation by matrix metalloproteinases: an in vitro and in vivo experiment. Phytomedicine, 2013, 20: 1203-1210.

[20] Liu J, . The promotion function of Berberine for osteogenic differentiation of human periodontal ligament stem cells via ERK-FOS pathway mediated by EGFR. Sci. Rep., 2018, 8

[21] Huang GT-J, Gronthos S, Shi S. Mesenchymal stem cells derived from dental tissues vs. those from other sources: their biology and role in regenerative medicine. J. Dent. Res., 2009, 88: 792-806.

[22] Huang GTJ, . Stem/progenitor cell–mediated de novo regeneration of dental pulp with newly deposited continuous layer of dentin in an in vivo model. Tissue Eng. Part A, 2010, 16: 605-615.

[23] He W, . Regulatory interplay between NFIC and TGF-β1 in apical papilla-derived stem cells. J. Dent. Res., 2014, 93: 496-501.

[24] Liu C, Xiong H, Chen K, Huang Y, Yin X. Long-term exposure to pro-inflammatory cytokines inhibits the osteogenic/dentinogenic differentiation of stem cells from the apical papilla. Int. Endod. J., 2016, 49: 950-959.

[25] Wang F, . Pro-inflammatory cytokine TNF-α attenuates BMP9-induced osteo/odontoblastic differentiation of the stem cells of dental apical papilla (SCAPs). Cell. Physiol. Biochem., 2017, 41: 1725-1735.

[26] Vishwanat L, . Effect of bacterial biofilm on the osteogenic differentiation of stem cells of apical papilla. J. Endod., 2017, 43: 916-922.

[27] Verma P, . Effect of residual bacteria on the outcome of pulp regeneration in vivo. J. Dent. Res., 2017, 96: 100-106.

[28] Bakopoulou A, . Comparative analysis of in vitro osteo/odontogenic differentiation potential of human dental pulp stem cells (DPSCs) and stem cells from the apical papilla (SCAP). Arch. Oral Biol., 2011, 56: 709-721.

[29] Zhou C, . Substrate compliance directs the osteogenic lineages of stem cells from the human apical papilla via the processes of mechanosensing and mechanotransduction. ACS Appl. Mater. Interfaces, 2019, 11: 26448-26459.

[30] Ercal P, Pekozer GG, Kose GT. Dental stem cells in bone tissue engineering: current overview and challenges. Adv. Exp. Med. Biol., 2018, 857: 113-127.

[31] Zhai Q, Dong Z, Wang W, Li B, Jin Y. Dental stem cell and dental tissue regeneration. Front. Med., 2019, 13: 152-159.

[32] Chrepa V, Pitcher B, Henry MA, Diogenes A. Survival of the apical papilla and its resident stem cells in a case of advanced pulpal necrosis and apical periodontitis. J. Endod., 2017, 43: 561-567.

[33] Liu F, Millar SE. Wnt/β-catenin signaling in oral tissue development and disease. J. Dent. Res., 2010, 89: 318-330.

[34] Wang J, Liu B, Gu S, Liang J. Effects of Wnt/β-catenin signalling on proliferation and differentiation of apical papilla stem cells. Cell Prolif., 2012, 45: 121-131.

[35] Zhang L-N, . Berberine improves advanced glycation end products‑induced osteogenic differentiation responses in human periodontal ligament stem cells through the canonical Wnt/β‑catenin pathway. Mol. Med. Rep., 2019, 19: 5440-5452.

[36] Zhang H, . Canonical Wnt signaling acts synergistically on BMP9-induced osteo/odontoblastic differentiation of stem cells of dental apical papilla (SCAPs). Biomaterials, 2015, 39: 145-154.

[37] Duan P, Bonewald LF. The role of the wnt/β-catenin signaling pathway in formation and maintenance of bone and teeth. Int. J. Biochem. Cell Biol., 2016, 77: 23-29.

[38] Wang J, Feng JQ. Signaling pathways critical for tooth root formation. J. Dent. Res., 2017, 96: 1221-1228.

[39] Nusse R, Clevers H. Wnt/β-catenin signaling, disease, and emerging therapeutic modalities. Cell, 2017, 169: 985-999.

[40] Liu X-Y, . FGF-7 dictates osteocyte cell processes through beta-catenin transduction. Sci. Rep., 2018, 8

[41] Behrens J, . Functional interaction of beta-catenin with the transcription factor LEF-1. Nature, 1996, 382: 638-642.

[42] Kahler RA, . Lymphocyte enhancer-binding factor 1 (Lef1) inhibits terminal differentiation of osteoblasts. J. Cell. Biochem., 2006, 97: 969-983.

[43] Xin, B. -C. et al. Berberine promotes osteogenic differentiation of human dental pulp stem cells through activating EGFR-MAPK-Runx2 pathways. Pathol. Oncol. Res. https://doi.org/10.1007/s12253-019-00746-6 (2019).

[44] Nakasone N, Yoshie H. Occlusion regulates tooth-root elongation during root development in rat molars. Eur. J. Oral Sci., 2011, 119: 418-426.

[45] Zhang J, Zhang W, Dai J, Wang X, Shen SG. Overexpression of Dlx2 enhances osteogenic differentiation of BMSCs and MC3T3-E1 cells via direct upregulation of osteocalcin and alp. Int. J. Oral Sci., 2019, 11: 12.